Progenics Pharma (NASDAQ: PGNX) August call option implied volatility is at 177, September is at 133; compared to its 52-week range of 57 to 173 into Valeant Pharmaceuticals International (VALEANT) and Progenics Pharmaceuticals announced that the FDA has approved RELISTOR Tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.